Jumlah Saham Beredar | 1,695,450 shares |
Saham Orang Dalam | 9,439,341 shares |
Orang Dalam Sejati | 26 |
Skor Sentimen Orang Dalam
Skor Sentimen Orang Dalam mengidentifikasi perusahaan yang dibeli oleh orang dalam korporat.
Ini adalah hasil dari model kuantitatif multifaktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi internal tertinggi. Model penilaian ini menggunakan kombinasi dari jumlah bersih orang dalam yang membeli dalam 90 hari sebelumnya, total saham yang dibeli sebagai persentase dari jumlah saham yang beredar, dan total saham yang dimiliki oleh orang dalam. Angka tersebut berkisar dari 0 hingga 100, dengan angka yang lebih tinggi menunjukkan tingkat akumulasi yang lebih tinggi dibandingkan dengan perusahaan sejenis, dan 50 adalah rata-rata.
Frekuensi Pembaruan: Setiap Hari
Skor Sentimen Petugas
Skor Sentimen Pejabat menemukan perusahaan yang dibeli oleh Pejabat Korporat.
Menurut definisi, Pejabat Korporasi adalah Orang Dalam Korporasi, tetapi tidak seperti beberapa Orang Dalam lainnya (Pemegang Saham 10% dan Anggota Dewan), Pejabat bekerja untuk perusahaan setiap hari, dan mereka menggunakan uang mereka sendiri saat bertransaksi . (Pemegang Saham 10% dan Anggota Dewan seringkali adalah manajer dana yang mengelola uang orang lain.) Dengan demikian, transaksi orang dalam yang dilakukan oleh Pejabat jauh lebih signifikan dan harus ditangani dengan tepat.
Seperti Skor Sentimen Internal, Skor Sentimen Pejabat adalah hasil dari model kuantitatif multi-faktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi pejabat tertinggi.
Frekuensi Pembaruan: Setiap Hari
Metrik Utama Orang Dalam
Kartu ini menunjukkan peringkat perusahaan berdasarkan berbagai metrik internal. Peringkat persentil menunjukkan bagaimana perusahaan ini dibandingkan dengan perusahaan lain di pasar AS. Peringkat yang lebih tinggi menunjukkan situasi yang lebih baik.
Sebagai contoh, secara umum diterima bahwa pembelian oleh orang dalam perusahaan adalah indikator positif, sehingga perusahaan dengan lebih banyak pembelian oleh orang dalam akan mendapat peringkat lebih tinggi daripada perusahaan dengan lebih sedikit pembelian oleh orang dalam (atau bahkan penjualan oleh orang dalam).
Jumlah Bersih Pembelian oleh Orang Dalam (Peringkat)
0 ( )
4590 out of 11305Jumlah Bersih Pembelian oleh Orang Dalam adalah total jumlah orang dalam yang membeli dikurangi total jumlah orang dalam yang menjual dalam 90 hari terakhir. Peringkat persentil ditunjukkan di sini (kisaran dari 0 hingga 100%).
Persentase Saham yang Dibeli oleh Orang Dalam (Peringkat)
0.000 %( )
4572 out of 11224Persentase Saham yang Dibeli oleh Orang Dalam adalah total jumlah saham yang dibeli oleh orang dalam dikurangi total jumlah saham yang dijual oleh orang dalam dalam 90 hari terakhir, dibagi dengan total jumlah saham yang beredar dan dikalikan dengan 100.
Grafik Perdagangan Orang Dalam
Grafik berikut menunjukkan Qualigen Therapeutics, Inc. transaksi orang dalam. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Secara umum, melakukan transaksi di perusahaan mereka berdasarkan informasi material yang belum dipublikasikan adalah ilegal bagi orang dalam. Ini tidak berarti bahwa mereka dilarang melakukan transaksi apa pun di perusahaan mereka sendiri. Namun, mereka wajib melaporkan semua transaksi kepada SEC melalui Formulir 4.
Daftar Orang Dalam dan Metrik Profitabilitas
Tabel ini menampilkan daftar orang dalam yang diketahui, dan dibuat secara otomatis dari pengajuan yang diungkapkan kepada SEC. Selain nama, jabatan terbaru, dan sebutan direktur, pejabat, atau pemilik 10%, kami memberikan kepemilikan terbaru yang diungkapkan. Selain itu, jika memungkinkan, kami memberikan kinerja perdagangan historis untuk orang dalam tersebut. Kinerja perdagangan historis adalah rata-rata tertimbang dari kinerja transaksi pembelian pasar terbuka aktual yang dilakukan oleh orang dalam tersebut. Untuk informasi lebih lanjut tentang bagaimana ini dihitung, tonton webinar YouTube ini.
See our leaderboard of most profitable insider traders.
Orang Dalam | Rata-rata Keuntungan (%) | Saham Dimiliki |
Terbagi Disesuaikan |
---|---|---|---|
Tariq Arshad | 300,000 | ||
Wajdi Abdul-Ahad | 500,000 | ||
Broidrick Amy S. President/CSO, Director - [D] [O] | 34,500 | 1,150 | |
John W Beck | 221,566 | ||
Jeffrey S Benjamin | 124,000 | ||
David Richard A. | 50,000 | ||
Noah Doyle Director - [D] | 704,780 | 704,780 | |
Sidney W Jr Emery Director - [D] | 19,682 | 656 |
Orang Dalam | Rata-rata Keuntungan (%) | Saham Dimiliki |
Terbagi Disesuaikan |
---|---|---|---|
Matthew W Foehr Director - [D] | 138,635 | 138,635 | |
Javelin Venture Partners I SPV I, LLC
10% Owner -
|
322,753 | 322,753 | |
Javelin Venture Partners, L.P.
10% Owner -
|
7,047,804 | 7,047,804 | |
Matthew E Korenberg | 50,000 | ||
Kurt H Kruger Director - [D] | 18,000 | 600 | |
Lotz Christopher L. Vice President of Finance, CFO - [O] | 12,541 | 418 | |
Samuel O Lynn | 0 | ||
Paul V Maier | 12,000 | ||
Merino William M. Director - [D] | 2,796 | 2,796 |
Orang Dalam | Rata-rata Keuntungan (%) | Saham Dimiliki |
Terbagi Disesuaikan |
---|---|---|---|
Mochizuki Ellen F. | 15,000 | ||
Gerald T Proehl Director - [D] | 50,000 | 50,000 | |
Poirier Michael S. Chairman and CEO, Director - [D] [O] | 210,207 | 7,007 | |
Andrew J Ritter CEO and President, Director - [D] [O] | 81,727 | 81,727 | |
Ritter Ira E. COB, CSO, Director - [D] [O] | 81,727 | 81,727 | |
Sekisui Diagnostics, Llc
10% Owner -
|
3,960,466 | 132,016 | |
Sinha Shishir K. | 500,000 | ||
Michael D Step CEO, Director - [D] [O] | 50,000 | 50,000 | |
Stonehenge Partners LLC
10% Owner -
|
817,272 | 817,272 |
Report errors via our new Insider Auditing Tool
Rekam Jejak Pembelian Orang Dalam - Analisis Keuntungan Jangka Pendek
Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di QLGN / Qualigen Therapeutics, Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoretis .
Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).
Rekam Jejak Penjualan Orang Dalam - Analisis Kerugian Jangka Pendek
Dalam bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan dalam pasar terbuka yang tidak direncanakan oleh orang dalam yang dilakukan di QLGN / Qualigen Therapeutics, Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoretis .
Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).
Riwayat Transaksi
Klik ikon tautan untuk melihat riwayat transaksi lengkap. Transaksi yang dilaporkan sebagai bagian dari rencana perdagangan otomatis 10b5-1 akan memiliki tanda X di kolom yang bertanda 10b-5.
Berkas Tanggal |
Perdagangan Tanggal |
Formulir | Orang Dalam | Ticker | Judul Keamanan | Kode | Langsung | Latihan Harga |
Satuan Harga |
Unit Diubah |
Nilai Diubah (1 ribu) |
Sisa Pilihan |
Sisa Saham |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2022-06-22 | 2022-06-22 | 4 | Poirier Michael S. | QLGN | Common Stock | D | 0.5700 | 30,000 | 17 | 199,202 | ||||
2022-06-15 | 2022-06-14 | 4 | BROIDRICK AMY S. | QLGN | Common Stock | D | 0.6200 | 30,000 | 19 | 34,500 | ||||
2021-12-10 | 2021-12-08 | 4 | ARSHAD TARIQ | QLGN | Stock Option (Right to Buy) | D | 1.24 | 300,000 | 300,000 | |||||
2021-12-10 | 2021-12-08 | 4 | BROIDRICK AMY S. | QLGN | Stock Option (Right to Buy) | D | 1.24 | 300,000 | 300,000 | |||||
2021-08-20 | 2021-08-19 | 4 | Kruger Kurt H | QLGN | Common Stock | D | 1.2200 | 4,000 | 5 | 18,000 | ||||
2021-08-20 | 2021-08-19 | 4 | Kruger Kurt H | QLGN | Common Stock | D | 1.2300 | 4,000 | 5 | 14,000 | ||||
2021-05-18 | 2021-05-17 | 4 | ARSHAD TARIQ | QLGN | Stock Option (Right to Buy) | D | 1.80 | 100,000 | 100,000 | |||||
2021-04-26 | 2021-04-26 | 4 | BROIDRICK AMY S. | QLGN | Common Stock | D | 2.0300 | 4,500 | 9 | 4,500 | ||||
2021-04-21 | 2021-04-20 | 4 | Poirier Michael S. By IRA | QLGN | Common Stock | I | 1.8000 | 11,005 | 20 | 11,005 | ||||
2021-04-19 | 2021-04-16 | 4 | Lotz Christopher L. | QLGN | Common Stock | D | 1.8600 | 2,700 | 5 | 12,541 | ||||
2020-12-30 | 2020-12-29 | 4 | Kruger Kurt H | QLGN | Common Stock | D | 2.9350 | 4,000 | 12 | 10,000 | ||||
2020-12-29 | 2020-12-07 | 4 | BROIDRICK AMY S. | QLGN | Stock Option (Right to Buy) | D | 3.52 | 150,000 | 150,000 | |||||
2020-12-08 | 2020-12-07 | 4 | EMERY SIDNEY W JR | QLGN | Stock Option (Right to Buy) | D | 3.52 | 50,000 | 50,000 | |||||
2020-12-07 | 3 | EMERY SIDNEY W JR | QLGN | Common Stock | D | 19,682 | ||||||||
2020-11-23 | 2020-11-23 | 4 | Kruger Kurt H | QLGN | Common Stock | D | 3.4620 | 4,600 | 16 | 6,000 | ||||
2020-11-23 | 2020-11-20 | 4 | Kruger Kurt H | QLGN | Common Stock | D | 3.5490 | 1,400 | 5 | 1,400 | ||||
2020-08-28 | 2020-08-27 | 4 | BROIDRICK AMY S. | QLGN | Stock Option (Right to Buy) | D | 4.70 | 50,000 | 50,000 | |||||
2020-06-08 | 2020-06-06 | 4 | Lotz Christopher L. | QLGN | Stock Option (Right to Buy) | D | 5.13 | 600,000 | 600,000 | |||||
2020-06-08 | 2020-06-06 | 4 | Korenberg Matthew E | QLGN | Stock Option (Right to Buy) | D | 5.13 | 50,000 | 50,000 | |||||
2020-06-08 | 2020-06-06 | 4 | Sinha Shishir K. | QLGN | Stock Option (Right to Buy) | D | 5.13 | 500,000 | 500,000 | |||||
2020-06-08 | 2020-06-06 | 4 | Kruger Kurt H | QLGN | Stock Option (Right to Buy) | D | 5.13 | 50,000 | 50,000 | |||||
2020-06-08 | 2020-06-06 | 4 | Abdul-Ahad Wajdi | QLGN | Stock Option (Right to Buy) | D | 5.13 | 500,000 | 500,000 | |||||
2020-06-08 | 2020-06-06 | 4 | Poirier Michael S. | QLGN | Stock Option (Right to Buy) | D | 5.13 | 1,000,000 | 1,000,000 | |||||
2020-06-08 | 2020-06-06 | 4 | David Richard A. | QLGN | Stock Option (Right to Buy) | D | 5.13 | 50,000 | 50,000 | |||||
2020-06-08 | 2020-06-06 | 4 | Ritter Ira E. | QLGN | Stock Option (Right to Buy) | D | 5.13 | 50,000 | 50,000 | |||||
2020-05-27 | 2020-05-22 | 4 | David Richard A. | QLGN | Warrant (Right to Buy) | D | 2.54 | 8,857 | 8,857 | |||||
2020-05-27 | 2020-05-22 | 4 | Kruger Kurt H | QLGN | Warrant (Right to Buy) | D | 2.54 | 8,857 | 8,857 | |||||
2020-05-27 | 2020-05-22 | 4 | Lotz Christopher L. | QLGN | Warrant (Right to Buy) | D | 2.54 | 3,543 | 3,543 | |||||
2020-05-27 | 2020-05-22 | 4 | Lotz Christopher L. | QLGN | Warrant (Right to Buy) | D | 2.07 | 22,142 | 22,142 | |||||
2020-05-27 | 2020-05-22 | 4 | Lotz Christopher L. | QLGN | Warrant (Right to Buy) | D | 2.54 | 22,142 | 22,142 | |||||
2020-05-27 | 2020-05-22 | 4 | Lotz Christopher L. | QLGN | Warrant (Right to Buy) | D | 2.07 | 29,847 | 29,847 | |||||
2020-05-27 | 2020-05-22 | 4 | Lotz Christopher L. | QLGN | Common Stock | D | 9,841 | 9,841 | ||||||
2020-05-27 | 2020-05-22 | 4 | Poirier Michael S. | QLGN | Warrant (Right to Buy) | D | 2.54 | 14,437 | 14,437 | |||||
2020-05-27 | 2020-05-22 | 4 | Poirier Michael S. | QLGN | Warrant (Right to Buy) | D | 2.07 | 22,142 | 22,142 | |||||
2020-05-27 | 2020-05-22 | 4 | Poirier Michael S. | QLGN | Warrant (Right to Buy) | D | 2.54 | 22,142 | 22,142 | |||||
2020-05-27 | 2020-05-22 | 4 | Poirier Michael S. | QLGN | Warrant (Right to Buy) | D | 2.07 | 29,847 | 29,847 | |||||
2020-05-27 | 2020-05-22 | 4 | Poirier Michael S. | QLGN | Common Stock | D | 169,192 | 169,192 | ||||||
2020-05-27 | 2020-05-22 | 4 | Sinha Shishir K. | QLGN | Warrant (Right to Buy) | D | 2.07 | 26,570 | 26,570 | |||||
2020-05-27 | 2020-05-22 | 4 | Sinha Shishir K. | QLGN | Warrant (Right to Buy) | D | 2.07 | 8,857 | 8,857 | |||||
2020-05-27 | 2020-05-22 | 4 | Abdul-Ahad Wajdi | QLGN | Warrant (Right to Buy) | D | 2.54 | 8,857 | 8,857 | |||||
2020-05-27 | 2020-05-22 | 4 | Abdul-Ahad Wajdi | QLGN | Warrant (Right to Buy) | D | 2.07 | 7,971 | 7,971 | |||||
2020-05-27 | 3 | SEKISUI DIAGNOSTICS, LLC | QLGN | COMMON STOCK | D | 3,960,466 | ||||||||
2020-05-27 | 3 | SEKISUI DIAGNOSTICS, LLC | QLGN | COMMON STOCK | D | 3,960,466 | ||||||||
2020-05-27 | 3 | SEKISUI DIAGNOSTICS, LLC | QLGN | COMMON STOCK | D | 3,960,466 | ||||||||
2020-05-19 | 2020-05-18 | 4 | Ritter Andrew J | RTTR | Non-qualified Stock Option (Right to Buy) | D | 0.64 | 583,068 | 583,068 | |||||
2020-05-19 | 2020-05-18 | 4 | Beck John W | RTTR | Non-qualified Stock Option (Right to Buy) | D | 0.64 | 221,566 | 221,566 | |||||
2020-05-19 | 2020-05-18 | 4 | Ritter Ira E. | RTTR | Non-qualified Stock Option (Right to Buy) | D | 0.64 | 361,502 | 361,502 | |||||
2020-04-23 | 2020-04-10 | 4 | FOEHR MATTHEW W | RTTR | Warrant Shares (right to buy) | D | 1.30 | -38,461 | 0 | |||||
2020-04-23 | 2020-04-10 | 4 | FOEHR MATTHEW W | RTTR | Common Stock | D | 38,461 | 138,635 | ||||||
2020-04-23 | 2020-01-21 | 4 | FOEHR MATTHEW W | RTTR | Series B convertible preferred stock | D | 1.30 | -100 | 0 | |||||
2020-04-23 | 2020-01-21 | 4 | FOEHR MATTHEW W | RTTR | Common Stock | D | 76,923 | 100,174 | ||||||
2020-03-16 | 2020-03-12 | 4 | Doyle Noah By Javelin Partners, L.P. | RTTR | Common Stock | I | 0.2200 | -500,000 | -110 | 704,780 | ||||
2020-03-13 | 2020-03-04 | 4 | Ritter Ira E. By Stonehenge Partners LLC | RTTR | Common Stock | I | 0.3756 | -18,750 | -7 | 81,727 | ||||
2020-03-13 | 2020-03-04 | 4 | Ritter Andrew J By Stonehenge Partners LLC | RTTR | Common Stock | I | 0.3756 | -18,750 | -7 | 81,727 | ||||
2020-02-27 | 2020-02-25 | 4 | Doyle Noah By Javelin Partners, L.P. | RTTR | Warrants (right to buy) | I | 0.15 | -500,000 | 0 | |||||
2020-02-27 | 2020-02-25 | 4 | Doyle Noah By Javelin Partners, L.P. | RTTR | Common Stock | I | 0.1500 | 500,000 | 75 | 1,204,780 | ||||
2020-01-17 | 2020-01-15 | 4 | Merino William M. | RTTR | Non-qualified Stock Option (Right to Buy) | D | 0.23 | 12,000 | 12,000 | |||||
2020-01-17 | 2020-01-15 | 4 | FOEHR MATTHEW W | RTTR | Non-qualified Stock Option (Right to Buy) | D | 0.23 | 12,000 | 12,000 | |||||
2020-01-17 | 2020-01-15 | 4 | Doyle Noah | RTTR | Non-qualified Stock Option (right to buy) | D | 0.23 | 12,000 | 12,000 | |||||
2020-01-17 | 2020-01-15 | 4 | MAIER PAUL V | RTTR | Non-qualified Stock Option (Right to Buy) | D | 0.23 | 12,000 | 12,000 | |||||
2019-02-08 | 2019-02-06 | 4 | Ritter Andrew J | RTTR | Non-qualified Stock Option (Right to Buy) | D | 0.60 | 252,000 | 252,000 | |||||
2019-02-08 | 2019-02-06 | 4 | Ritter Ira E. | RTTR | Non-Qualified Stock Option (Right to Buy) | D | 0.60 | 200,000 | 200,000 | |||||
2019-02-08 | 2019-02-06 | 4 | Merino William M. | RTTR | Non-qualified Stock Option (Right to Buy) | D | 0.60 | 15,000 | 15,000 | |||||
2019-02-08 | 2019-02-06 | 4 | Merino William M. | RTTR | Non-qualified Stock Option (Right to Buy) | D | 0.60 | 15,000 | 15,000 | |||||
2019-02-08 | 2019-02-06 | 4 | Doyle Noah | RTTR | Non-qualified Stock Option (right to buy) | D | 0.60 | 15,000 | 15,000 | |||||
2019-02-08 | 2019-02-06 | 4 | FOEHR MATTHEW W | RTTR | Non-qualified Stock Option (Right to Buy) | D | 0.60 | 15,000 | 15,000 | |||||
2019-02-08 | 2019-02-06 | 4 | Beck John W | RTTR | Non-qualified Stock Option (Right to Buy) | D | 0.60 | 105,000 | 105,000 | |||||
2019-02-08 | 2019-02-06 | 4 | MAIER PAUL V | RTTR | Non-qualified Stock Option (Right to Buy) | D | 0.60 | 15,000 | 15,000 | |||||
2018-11-07 | 2018-11-05 | 4 | FOEHR MATTHEW W | RTTR | Warrant Shares (right to buy) | D | 1.30 | 38,461 | 38,461 | |||||
2018-11-07 | 2018-11-05 | 4 | FOEHR MATTHEW W | RTTR | Series B convertible preferred stock | D | 1.30 | 100 | 100 | |||||
2018-09-19 | 2018-08-17 | 4/A | FOEHR MATTHEW W | RTTR | Common Stock | D | 2.0400 | 19,751 | 40 | 23,251 | ||||
2018-08-20 | 2018-08-17 | 4 | FOEHR MATTHEW W | RTTR | Common Stock | D | 2.0400 | 19,751 | 40 | 54,751 | ||||
2018-06-27 | 2018-06-26 | 4 | Ritter Andrew J | RTTR | Non-qualified Stock Option (Right to Buy) | D | 2.73 | 150,000 | 150,000 | |||||
2018-05-25 | 2018-05-23 | 4 | Beck John W | RTTR | Non-qualified Stock Option (Right to Buy) | D | 3.32 | 100,000 | 100,000 | |||||
2018-01-25 | 2018-01-23 | 4 | MAIER PAUL V | RTTR | Non-qualified Stock Option (Right to Buy) | D | 0.34 | 30,000 | 30,000 | |||||
2018-01-25 | 2018-01-23 | 4 | Doyle Noah | RTTR | Non-qualified Stock Option (right to buy) | D | 0.34 | 30,000 | 30,000 | |||||
2018-01-25 | 2018-01-23 | 4 | PROEHL GERALD T | RTTR | Non-qualified Stock Option (Right to Buy) | D | 0.34 | 30,000 | 30,000 | |||||
2018-01-25 | 2018-01-23 | 4 | Ritter Andrew J | RTTR | Non-qualified Stock Option (Right to Buy) | D | 0.34 | 495,065 | 495,065 | |||||
2018-01-25 | 2018-01-23 | 4 | Step Michael D | RTTR | Non-qualified Stock Option (Right to Buy) | D | 0.34 | 495,065 | 495,065 | |||||
2018-01-25 | 2018-01-23 | 4 | Merino William M. | RTTR | Non-qualified Stock Option (Right to Buy) | D | 0.34 | 30,000 | 30,000 | |||||
2018-01-25 | 2018-01-23 | 4 | FOEHR MATTHEW W | RTTR | Non-qualified Stock Option (Right to Buy) | D | 0.34 | 30,000 | 30,000 | |||||
2018-01-25 | 2018-01-23 | 4 | Benjamin Jeffrey S | RTTR | Non-qualified Stock Option (right to buy) | D | 0.34 | 124,000 | 124,000 | |||||
2018-01-25 | 2018-01-23 | 4 | Ritter Ira E. | RTTR | Non-Qualified Stock Option (Right to Buy) | D | 0.34 | 495,065 | 495,065 | |||||
2017-10-27 | 2017-10-03 | 4 | Javelin Venture Partners, L.P. | RTTR | Warrants (right to buy) | D | 0.44 | 5,000,000 | 5,000,000 | |||||
2017-10-27 | 2017-10-03 | 4 | Javelin Venture Partners, L.P. | RTTR | Common Stock | D | 5,000,000 | 7,047,804 | ||||||
2017-10-27 | 2017-10-03 | 4 | Doyle Noah by Javelin Venture Partners, L.P. | RTTR | Warrants (right to buy) | I | 0.44 | 5,000,000 | 5,000,000 | |||||
2017-10-27 | 2017-10-03 | 4 | Doyle Noah by Javelin Venture Partners, L.P. | RTTR | Common Stock | I | 5,000,000 | 7,047,804 | ||||||
2017-10-27 | 2017-10-03 | 4 | Ritter Ira E. by Stonehenge Partners LLC | RTTR | Warrants (right to buy) | I | 0.44 | 187,500 | 187,500 | |||||
2017-10-27 | 2017-10-03 | 4 | Ritter Ira E. by Stonehenge Partners LLC | RTTR | Common Stock | I | 187,500 | 1,004,772 | ||||||
2017-10-27 | 2017-10-03 | 4 | Ritter Andrew J By Stonehenge Partners LLC | RTTR | Warrants (Right to Buy) | I | 0.44 | 187,500 | 187,500 | |||||
2017-10-27 | 2017-10-03 | 4 | Ritter Andrew J By Stonehenge Partners LLC | RTTR | Common Stock | I | 187,500 | 1,004,772 | ||||||
2017-05-18 | 2017-05-18 | 4 | FOEHR MATTHEW W | RTTR | Common Stock | D | 0.6197 | 18,000 | 11 | 35,000 | ||||
2017-05-12 | 2017-05-11 | 4 | Step Michael D By Michael D. Step Family Trust | RTTR | Common Stock | I | 0.6159 | 13,000 | 8 | 50,000 | ||||
2017-02-28 | 2017-02-27 | 4 | Step Michael D By Michael D. Step Family Trust | RTTR | Common Stock | I | 2.6500 | 8,000 | 21 | 37,000 | ||||
2017-02-28 | 2017-02-27 | 4 | Step Michael D By Michael D. Step Family Trust | RTTR | Common Stock | I | 2.6400 | 2,000 | 5 | 29,000 | ||||
2017-02-01 | 3 | Merino William M. | RTTR | Common Stock | D | 2,796 | ||||||||
2017-02-01 | 3 | Merino William M. | RTTR | Common Stock | D | 2,796 | ||||||||
2017-02-01 | 2017-01-25 | 4 | Merino William M. | RTTR | Non-qualified Stock Option (Right to Buy) | D | 2.89 | 10,000 | 10,000 | |||||
2017-01-27 | 2017-01-25 | 4 | Step Michael D | RTTR | Non-qualified Stock Option (Right to Buy) | D | 2.89 | 58,000 | 58,000 | |||||
2017-01-27 | 2017-01-25 | 4 | Mochizuki Ellen F. | RTTR | Non-qualified Stock Option (Right to Buy) | D | 2.89 | 15,000 | 15,000 | |||||
2016-11-30 | 2016-11-29 | 4 | FOEHR MATTHEW W | RTTR | Stock Option (2015 Equity Incentive Plan) | D | 2.37 | 7,000 | 7,000 | |||||
2016-11-30 | 2016-11-29 | 4 | MAIER PAUL V | RTTR | Stock Option (2015 Equity Incentive Plan) | D | 2.37 | 7,000 | 7,000 | |||||
2016-11-30 | 2016-11-29 | 4 | PROEHL GERALD T | RTTR | Stock Option (2015 Equity Incentive Plan) | D | 2.37 | 7,000 | 7,000 | |||||
2016-11-15 | 3/A | Doyle Noah | RTTR | Common Stock | D | 22,727 | ||||||||
2016-10-25 | 2016-10-25 | 4 | Ritter Andrew J | RTTR | Non-qualified Stock Option (Right to Buy) | D | 2.60 | 140,044 | 140,044 | |||||
2016-10-25 | 2016-10-25 | 4 | Ritter Ira E. | RTTR | Non-qualified Stock Option (Right to Buy) | D | 2.60 | 140,044 | 140,044 | |||||
2016-07-07 | 2016-07-05 | 4 | Step Michael D | RTTR | Non-qualified Stock Option (Right to Buy) | D | 1.54 | 82,000 | 82,000 | |||||
2016-07-07 | 2016-07-05 | 4 | Ritter Andrew J | RTTR | Non-qualified Stock Option (Right to Buy) | D | 1.54 | 82,000 | 82,000 | |||||
2016-07-07 | 2016-07-05 | 4 | Ritter Ira E. | RTTR | Non-qualified Stock Option (Right to Buy) | D | 1.54 | 82,000 | 82,000 | |||||
2016-02-24 | 2016-02-22 | 4 | Ritter Andrew J | RTTR | Common Stock | D | 1.6000 | 6,250 | 10 | 6,250 | ||||
2016-02-24 | 2016-02-22 | 4 | Ritter Ira E. By trust | RTTR | Common Stock | I | 1.6000 | 6,250 | 10 | 6,250 | ||||
2016-01-29 | 2016-01-26 | 4 | Mochizuki Ellen F. | RTTR | Stock Options (2015 Equity Incentive Plan) | D | 1.39 | 10,000 | 10,000 | |||||
2016-01-11 | 2016-01-08 | 4 | FOEHR MATTHEW W | RTTR | Common Stock | D | 1.6400 | 13,000 | 21 | 17,000 | ||||
2016-01-08 | 2016-01-07 | 4 | Step Michael D | RTTR | Common Stock | D | 1.4800 | 27,000 | 40 | 27,000 | ||||
2015-10-15 | 2015-10-13 | 4 | PROEHL GERALD T | RTTR | Stock Option (2015 Equity Incentive Plan) | D | 2.25 | 10,000 | 10,000 | |||||
2015-10-15 | 2015-10-13 | 4 | FOEHR MATTHEW W | RTTR | Stock Option (2015 Equity Incentive Plan) | D | 2.25 | 10,000 | 10,000 | |||||
2015-10-15 | 2015-10-13 | 4 | MAIER PAUL V | RTTR | Stock Option (2015 Equity Incentive Plan) | D | 2.25 | 10,000 | 10,000 | |||||
2015-06-30 | 2015-06-29 | 4 | Javelin Venture Partners, L.P. | RTTR | Convertible Preferred Stock | D | -1,247,804 | 0 | ||||||
2015-06-30 | 2015-06-29 | 4 | Javelin Venture Partners, L.P. | RTTR | Common Stock | D | 1,247,804 | 2,047,804 | ||||||
2015-06-30 | 2015-06-29 | 4 | Ritter Andrew J by Stonehenge Partners LLC | RTTR | Convertible Preferred Stock | I | -817,272 | 0 | ||||||
2015-06-30 | 2015-06-29 | 4 | Ritter Andrew J by Stonehenge Partners LLC | RTTR | Common Stock | I | 817,272 | 817,272 | ||||||
2015-06-30 | 2015-06-29 | 4 | Doyle Noah by Javelin Venture Partners I SPV I, LLC | RTTR | Convertible Preferred Stock | I | -322,753 | 0 | ||||||
2015-06-30 | 2015-06-29 | 4 | Doyle Noah by Javelin Venture Partners, L.P. | RTTR | Convertible Preferred Stock | I | -1,247,804 | 0 | ||||||
2015-06-30 | 2015-06-29 | 4 | Doyle Noah by Javelin Venture Partners I SPV I, LLC | RTTR | Common Stock | I | 322,753 | 322,753 | ||||||
2015-06-30 | 2015-06-29 | 4 | Doyle Noah by Javelin Venture Partners, L.P. | RTTR | Common Stock | I | 1,247,804 | 2,047,804 | ||||||
2015-06-30 | 2015-06-29 | 4 | Ritter Ira E. by Stonehenge Partners LLC | RTTR | Convertible Preferred Stock | I | -817,272 | 0 | ||||||
2015-06-30 | 2015-06-29 | 4 | Ritter Ira E. by Stonehenge Partners LLC | RTTR | Common Stock | I | 817,272 | 817,272 | ||||||
2015-06-30 | 2015-06-29 | 4 | Stonehenge Partners LLC | RTTR | Convertible Preferred Stock | D | -817,272 | 0 | ||||||
2015-06-30 | 2015-06-29 | 4 | Stonehenge Partners LLC | RTTR | Common Stock | D | 817,272 | 817,272 | ||||||
2015-06-30 | 2015-06-29 | 4 | Javelin Venture Partners I SPV I, LLC | RTTR | Convertible Preferred Stock | D | -322,753 | 0 | ||||||
2015-06-30 | 2015-06-29 | 4 | Javelin Venture Partners I SPV I, LLC | RTTR | Common Stock | D | 322,753 | 322,753 | ||||||
2015-06-25 | 2015-06-24 | 4 | FOEHR MATTHEW W | RTTR | Common Stock | D | 5.0000 | 4,000 | 20 | 4,000 | ||||
2015-06-25 | 2015-06-24 | 4 | PROEHL GERALD T | RTTR | Common Stock | D | 5.0000 | 50,000 | 250 | 50,000 | ||||
2015-06-25 | 2015-06-24 | 4 | Javelin Venture Partners, L.P. | RTTR | Common Stock | D | 5.0000 | 800,000 | 4,000 | 800,000 | ||||
2015-06-25 | 2015-06-24 | 4 | Doyle Noah by Javelin Venture Partners, L.P. | RTTR | Common Stock | I | 5.0000 | 800,000 | 4,000 | 800,000 |